Searched for
ASTELLAS PHARMA INDIA
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- No longer just leisurely weekend escapes, pickleball & padel emerge as go-to sports for business leadersPickleball and padel are rapidly growing in India, driven by their social nature and ease of play. Urban millennials, professionals and fam...
- Lupin rallies 4% after multiple approvals from USFDAIn a regulatory filing, the company said it has received approval from the USFDA for mirabegron extended-release tablets.
- Stocks in the news: Here Moto, Indian Oil, Lupin, PNB and Adani Group stocksHero MotoCorp, the two-wheeler manufacturer, said it will invest $60 million in US-based Zero motorcycles to jointly develop electric motor...
- Strides Pharma suspends sale of Ranitidine tab in USIn a regulatory filing, the company said it has received an Information Request from the USFDA to provide test data related to NDMA impurit...
- Stocks in the news: Cox & Kings, Sadbhav Infra, Lupin, Tata Steel & Sun PharmaNMDC has terminated a Rs 1,400-cr contract with BHEL for building the raw material handling system.
- Precision medicine: Zuckerberg backs Indian-origin scientist with formula to jolt drug marketDr Butte's aim is drug re-positioning. It is not about getting a new drug out in the market, but finding a new use for an old drug that's a...
- Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brandsThe acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.
- Astellas aims to emerge top player in transplantationJapan’s second-largest pharma company, the $10-billion Astellas Pharma, intends to emerge as a niche player in India.
- Ranbaxy loses out on FDA delayRanbaxy, the Indian unit of Japanese drugmaker Daiichi Sankyo, was to launch the generic version of the Japan-based Astellas’ Flomax on Mar...
- Ranbaxy to shift admin to MumbaiRanbaxy Laboratories, India’s largest pharma company by sales, is looking to shift its marketing and administrative teams from its Gurgaon ...
- Indian generic companies may tread Ranbaxy pathRanbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterpar...
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
- Ranbaxy settles generic sale dispute with GSKRanbaxy Laboratories has reached an out-of-court settlement with UK’s pharma major GlaxoSmithKline to market generic copies of the latter’s...
Load More
